MAIN ARTICLE
Following products after they leave the warehouse
The route described in documents reviewed by Reuters runs from company warehouses to disposal contractors, unlicensed sorting yards, brokers and retailers. At the yards, investigators allege, packages that still looked saleable were selected for a return to the market. This is an account advanced in the investigation, not a judicial determination. Its significance lies in a neglected part of the supply chain: removing stock from a warehouse does not by itself establish what happened afterwards. A product designated for disposal still needs a destination that can be checked.
The FDA says it visited warehouses of Reliance Retail, Reliance Consumer and Zomato Hyperpure. In one Hyperpure warehouse, a representative identified a disposal contractor whom inspectors could not trace, according to the documents. Reuters' report does not establish the complete volume involved, every final purchaser or a total of health harm. Those gaps matter. It would be misleading to extend the allegations to every product sold by the businesses concerned. Investigators need to establish the affected stock and the role of each participant, while the companies and individuals have the opportunity to answer the allegations.















